HPV-associated oropharyngeal cancer

被引:14
|
作者
Sheedy, Trina [1 ]
Heaton, Chase [1 ]
机构
[1] Univ Calif San Francisco, Med Ctr, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94115 USA
关键词
human papillomavirus; HPV; vaccine; oropharyngeal squamous cell carcinoma; physician assistant; HUMAN-PAPILLOMAVIRUS; NECK-CANCER; UNITED-STATES; HEAD; VACCINATION; PREVALENCE; INFECTIONS; KNOWLEDGE;
D O I
10.1097/01.JAA.0000578756.52642.cb
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Exposure of the oral cavity and oropharynx to human papillomavirus (HPV) often results in an asymptomatic, transient oral infection that is cleared by the body's immune system; however, a small percentage of these oral infections can persist in a dormant state. Depending on the HPV genotype, a persistent oral infection may lead to benign or malignant disease. High-risk HPV types 16 and 18, which cause most cervical and anal cancers, also are the cause of the rising rate of oropharyngeal squamous cell carcinoma (SCC) in the United States. This article focuses on the epidemiology, transmission, risk factors, and clinical presentation of HPV-associated oropharyngeal SCC, and provides an update on HPV vaccination in the context of the new head and neck cancer epidemic.
引用
收藏
页码:26 / 31
页数:6
相关论文
共 50 条
  • [31] HPV-associated oropharyngeal cancer: in search of surrogate biomarkers for early lesions
    Yvonne X. Lim
    Nisha J. D’Silva
    [J]. Oncogene, 2024, 43 : 543 - 554
  • [32] Trends of two HPV-associated cancers in Massachusetts: cervical and oropharyngeal cancer
    Erin E. Cook
    Susan T. Gershman
    Jane J. Kim
    Rulla M. Tamimi
    R. Monina Klevens
    Michelle D. Holmes
    [J]. Cancer Causes & Control, 2018, 29 : 435 - 443
  • [33] HPV-associated oropharyngeal squamous cell carcinoma
    Smith, Timothy J.
    Mendez, Anthony
    Donald, Carrlene
    Nagel, Thomas Harold
    [J]. JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2017, 30 (01): : 14 - 19
  • [34] Identification of novel methylation markers in HPV-associated oropharyngeal cancer.
    Misawa, Kiyoshi
    Mima, Masato
    Mineta, Hiroyuki
    [J]. CANCER SCIENCE, 2021, 112 : 859 - 859
  • [35] HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management
    Lechner, Matt
    Liu, Jacklyn
    Masterson, Liam
    Fenton, Tim R.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2022, 19 (05) : 306 - 327
  • [36] HPV-associated oropharyngeal cancer: in search of surrogate biomarkers for early lesions
    Lim, Yvonne X.
    D'Silva, Nisha J.
    [J]. ONCOGENE, 2024, 43 (08) : 543 - 554
  • [37] Is HPV-Associated Oropharyngeal Cancer Becoming More Common in Older Patients?
    Thompson, James D.
    Harari, Paul M.
    Hartig, Gregory K.
    [J]. LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY, 2018, 3 (06): : 446 - 449
  • [38] HPV-associated oropharyngeal cancer-incidence, trends, diagnosis, and treatment
    Wagner, S.
    Reder, H.
    Sharma, S. J.
    Wuerdemann, N.
    Wittekindt, C.
    Klussmann, J. P.
    [J]. UROLOGE, 2018, 57 (12): : 1457 - 1463
  • [39] Impact of Tobacco Smoking on Mutational Landscape in HPV-Associated Oropharyngeal Cancer
    Lilja-Fischer, J.
    Ulhoi, B.
    Alsner, J.
    Stougaard, M.
    Lassen, P.
    Steiniche, T.
    Overgaard, J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (05): : 1317 - 1318
  • [40] Decreased overall survival in black patients with HPV-associated oropharyngeal cancer
    Sheth, Siddharth
    Farquhar, Douglas R.
    Lenze, Nicholas R.
    Mazul, Angela
    Brennan, Paul
    Anantharaman, Devasena
    Abedi-Ardekani, Behnoush
    Zevallos, Jose P.
    Hayes, D. Neil
    Olshan, F.
    [J]. AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2021, 42 (01)